Grant: Development and clinical evaluation of peptide vaccines for immunotherapy of Epstein-Barr virus-positive nasopharyngeal carcinoma
| Project Title |
Development and clinical evaluation of peptide vaccines for immunotherapy of Epstein-Barr virus-positive nasopharyngeal carcinoma
|
|---|---|
| Principal Investigator | Dr Lin Chen-Lung (Principal investigator) |
| Co-Investigator(s) |
Tam, Paul Kwong Hang
(Co-Investigator)
Che, Chi Ming (Co-Investigator) Professor Zeng Yixin (Co-Investigator) Dr Guo Zhihong (Co-Investigator) Dr Meng Mingie (Co-Investigator) Professor Wang Xiaoning (Co-principal investigator) |
| Project Code |
N_HKU 721/04
|
| Funding Year |
2004/2005
|
| Amount |
631403
|
| Start Date |
01-12-2004
|
| Expected Completion |
30-11-2007
|
| Status |
Completed
|
| Keywords | life science |
| Sponsor | NSFC/RGC Joint Research Scheme |
| Grant Type/Funding Scheme | NSFC/RGC Joint Research Scheme |
| Duration |
36
|
| Publication | Conjugation of latent membrane protein (LMP)-2 epitope to gold nanoparticles as highly immunogenic multiple antigenic peptides for induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses in vitro |
[Coming Soon]